Clinical

Dataset Information

0

A Study of Novel Oncology Therapies in Combination with FOLFOX and Bevacizumab in Metastatic Microsatellite-Stable Colorectal Cancer


ABSTRACT: Primary objectives: Part 1: To evaluate the safety and tolerability profile of FOLFOX + bevacizumab + novel oncology therapy combinations Part 2: To compare the efficacy of FOLFOX + bevacizumab + novel oncology therapy combinations versus FOLFOX + bevacizumab Primary endpoints: Part 1: Incidence of adverse events (AEs), serious adverse events (SAEs), dose-limiting toxicities (DLTs), laboratory findings, and vital signs Part 2: Objective response (OR) per RECIST v1.1

DISEASE(S): Cáncer Colorrectal Con Microsatélites Estables Metastásico,Metastatic Colorectal Cancer,Metastatic Microsatellite-stable Colorectal Cancer

PROVIDER: 2538990 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2272349 | ecrin-mdr-crc
2011-03-25 | GSE21228 | GEO
2023-07-20 | GSE232525 | GEO
2019-08-20 | GSE110146 | GEO
2024-08-26 | GSE275628 | GEO
2019-07-25 | GSE134817 | GEO
| 2314668 | ecrin-mdr-crc
2021-09-09 | PXD016604 | Pride
| 2168893 | ecrin-mdr-crc
2024-01-20 | GSE236438 | GEO